Biohaven Ltd. BHVN
15.24 USD 0.00 (+0.00%)
At closeNov 5, 2026, 9:16 AM EST
15.32 +0.08 +0.52%
Pre-market · Nov 5, 9:16 AM ET
15.12 Day range 16.15
7.48 52-week range 18.24
- YTD
- +34.99%
- 1 year
- +82.73%
Analyst view
Consensus: buy
Buy
Price target (mean) 23.73 +55.7% upside
Now 15.24
- Target (low)
- 9.00
- Target (mean)
- 23.73
- Target (high)
- 48.00
Ratings (0m) 17 12 buy · 4 hold · 1 sell
- Strong buy3
- Buy9
- Hold4
- Sell0
- Strong sell1
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 17
- 3 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.60338 | -0.64324 – 1.87 | -0.90 | +167.0% | 109.33M | 0.0% | 4 |
| Next quarter | -0.46 | -0.46 – -0.46 | -0.69 | +33.3% | 11.72M | 0.0% | 1 |
| Current year | -1.18 | -2.85 – -0.05997 | -5.55 | +78.8% | 138.00M | 0.0% | 5 |
| Next year | -1.87 | -2.62 – -1.21 | -1.18 | -58.4% | 80.77M | -41.5% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 23, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Sep 10, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Sep 8, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 29, 2026 | B of A Securities | Downgrade | Neutral | Underperform |
| May 26, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 11, 2026 | TD Cowen | Maintained | Buy | Buy |
| Mar 4, 2026 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Mar 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 21, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Jan 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Dec 26, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Dec 3, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 26, 2025 | UBS | Downgrade | Buy | Neutral |
| Nov 20, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | BTIG | Reiterated | Buy | Buy |
| Nov 13, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 6, 2025 | Bernstein | Downgrade | Outperform | Market Perform |
| Nov 6, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 5, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 5, 2025 | TD Cowen | Maintained | Buy | Buy |
| Sep 17, 2025 | Citigroup | Initiated | — | Buy |
